Walter A. Kukull

Walter A. Kukull's AcademicInfluence.com Rankings

Walter A. Kukull

Philosophy

#6006

World Rank

#8964

Historical Rank

Logic

#3200

World Rank

#4321

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Walter A. Kukull's Degrees

PhD Epidemiology University of Washington
Masters Biostatistics University of Washington
Bachelors Biology University of Washington

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Walter A. Kukull Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walter A. Kukull's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) (3484)
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis (1997) (3245)
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. (1997) (2488)
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease (1996) (2328)
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
Diagnosis and management of dementia with Lewy bodies (2017) (1606)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) (1494)
Analysis of shared heritability in common disorders of the brain (2016) (1385)
Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older (2006) (1238)
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) (1230)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
Primary age-related tauopathy (PART): a common pathology associated with human aging (2014) (988)
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (1994) (924)
Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. (1996) (884)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) (793)
Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. (2003) (784)
Dementia and Alzheimer disease incidence: a prospective cohort study. (2002) (726)
The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers (2006) (704)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) (646)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease (2009) (621)
The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery (2009) (588)
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. (2013) (572)
Depression as a risk factor for Alzheimer disease: the MIRAGE Study. (2003) (524)
The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (2007) (506)
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons (2008) (486)
Head injury and the risk of AD in the MIRAGE study (2000) (456)
GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers (2007) (452)
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. (2010) (426)
Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease (1995) (392)
National estimates of the prevalence of Alzheimer’s disease in the United States (2011) (365)
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis (2017) (363)
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. (2013) (345)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis (2017) (329)
Adverse drug reactions associated with global cognitive impairment in elderly persons. (1987) (316)
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. (1994) (308)
Progression to dementia in patients with isolated memory loss (1997) (303)
Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias (2014) (295)
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study (1996) (288)
The Mini-Mental State Examination score and the clinical diagnosis of dementia. (1994) (283)
APOE ε4 increases risk for dementia in pure synucleinopathies. (2013) (282)
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. (2007) (277)
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score (2017) (277)
Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. (2008) (258)
The National Alzheimer's Coordinating Center (NACC) Database: An Alzheimer Disease Database (2004) (249)
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. (2007) (247)
New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN (2015) (246)
Mutations in COQ2 in familial and sporadic multiple-system atrophy. (2013) (246)
Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both (2005) (244)
Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS) (2017) (236)
History of Depression as a Risk Factor for Alzheimer's Disease (1995) (233)
Survival after Initial Diagnosis of Alzheimer Disease (2004) (224)
Characteristics of Sleep Disturbance in Community-Dwelling Alzheimer's Disease Patients (1999) (216)
Subjective Memory Deterioration and Future Dementia in People Aged 65 and Older (2004) (213)
Anxiety of Alzheimer's disease: prevalence, and comorbidity. (1999) (202)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
Outcome-Based Doctor-Patient Interaction Analysis: II. Identifying Effective Provider and Patient Behavior (1982) (192)
Outcome-Based Doctor-Patient Interaction Analysis: I. Comparison of Techniques (1982) (191)
Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study (1992) (189)
Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau (2018) (186)
Epidemiology of dementia: concepts and overview. (2000) (185)
Early-life risk factors and the development of Alzheimer’s disease (2000) (182)
Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. (1995) (181)
Footwear Style and Risk of Falls in Older Adults (2004) (178)
Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. (1997) (172)
Statin therapy and risk of dementia in the elderly (2004) (172)
Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
Generalizability: the trees, the forest, and the low-hanging fruit. (2012) (168)
Biomechanical Properties of Shoes and Risk of Falls in Older Adults (2004) (165)
The validity of 3 clinical diagnostic criteria for Alzheimer's disease (1990) (164)
Symptomatic Depression in Elderly Medical Outpatients (1986) (161)
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease (2006) (159)
Cognitive impairment: dementia and Alzheimer's disease. (1992) (158)
Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set (2018) (154)
Symptom Patterns and Comorbidity in the Early Stages of Alzheimer's Disease (1994) (149)
Transethnic genome-wide scan identifies novel Alzheimer's disease loci (2017) (149)
Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease (2006) (142)
Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease (1998) (141)
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology (2012) (135)
Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. (2002) (132)
Atherosclerosis and AD (2005) (131)
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS) (2016) (123)
Using Census Data and Birth Certificates to Reconstruct the Early-Life Socioeconomic Environment and the Relation to the Development of Alzheimer’s Disease (2001) (123)
Predictors of mortality in patients diagnosed with probable Alzheimer's disease (1996) (121)
Body Mass Index, Weight Change, and Clinical Progression in Mild Cognitive Impairment and Alzheimer Disease (2014) (120)
Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. (1995) (116)
Serum cholesterol and risk of Alzheimer disease (2005) (112)
Age‐Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community‐Based Prospective Cohort Study (2007) (109)
Wandering: a significant problem among community-residing individuals with Alzheimer's disease. (1998) (108)
The Alzheimer ’ s Disease Centers ’ Uniform Data Set ( UDS ) : The Neuropsychological Test Battery (2009) (107)
RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy‐Related Pathology in the Dementia Patient (2008) (107)
Education, cognitive function, and severity of neuropathology in Alzheimer disease (2008) (106)
Neighborhood Environment and Cognition in Older Adults: A Systematic Review. (2017) (102)
Exercise and activity level in Alzheimer's disease: a potential treatment focus. (1998) (101)
Age‐Varying Association Between Statin Use and Incident Alzheimer's Disease (2010) (101)
Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes (2015) (100)
Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study (2011) (100)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
Interrater reliability of Alzheimer's disease diagnosis (1990) (98)
Variants associated with Gaucher disease in multiple system atrophy (2015) (97)
Depression and physical illness among elderly general medical clinic patients. (1986) (96)
APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease. (1991) (95)
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. (2014) (95)
Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans (2014) (92)
The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. (1994) (90)
Causes of Death Associated with Alzheimer Disease: Variation by Level of Cognitive Impairment Before Death (1994) (90)
The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses (2018) (89)
Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. (1998) (89)
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
Tumor necrosis factor α and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease (2006) (85)
Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. (2014) (83)
Dementia epidemiology. (2002) (83)
History of head trauma and risk of intracranial meningioma: Population-based case-control study (2002) (82)
Symptom Distress, Psychosocial Variables, and Survival From Lung Cancer (1986) (81)
The North American Multiple System Atrophy Study Group (2005) (80)
Anxiety Symptoms as Predictors of Nursing Home Placement in Patients with Alzheimer's Disease (2002) (80)
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2019) (77)
Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study (2016) (75)
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. (2005) (75)
Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample (2017) (74)
Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis (2011) (74)
Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (73)
Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology (2010) (73)
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology (2014) (72)
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. (2015) (71)
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals (2017) (70)
The cognitive abilities screening instrument (CASI): data from a cohort of 2524 cognitively intact elderly (1999) (70)
The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type (1998) (70)
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans (2017) (67)
Dementia registries around the globe and their applications: A systematic review (2017) (66)
Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology (2014) (66)
University of Washington Alzheimer’s Disease Patient Registry (ADPR): 1987–8 (1990) (66)
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (65)
Drinking water aluminum and bioavailability (1995) (64)
Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples (1996) (63)
Neuropathologic differences by race from the National Alzheimer's Coordinating Center (2016) (63)
Healthcare Utilization and Costs in Managed Care Patients with Alzheimer's Disease During the Last Few Years of Life (2001) (62)
Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples (2017) (61)
Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia (2016) (60)
Associations Between Microinfarcts and Other Macroscopic Vascular Findings on Neuropathologic Examination in 2 Databases (2009) (58)
Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study. (1996) (57)
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium (2020) (56)
Shared genetic contribution to ischemic stroke and Alzheimer's disease (2016) (55)
Polygenic hazard score, amyloid deposition and Alzheimer’s neurodegeneration (2019) (53)
The association between smoking and Alzheimer’s disease: effects of study design and bias (2001) (53)
Rapid eye movement sleep measures of Alzheimer's-type dementia patients and optimally healthy aged individuals. (1984) (53)
Sex differences in the genetic predictors of Alzheimer's pathology. (2019) (51)
Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology (2013) (50)
Reassessment of Risk Genotypes (GRN, TMEM106B, and ABCC9 Variants) Associated With Hippocampal Sclerosis of Aging Pathology (2015) (49)
Generalizability (2012) (47)
Physical activity and subarachnoid haemorrhage: a population based case-control study (2000) (46)
Polygenic hazard scores in preclinical Alzheimer’s disease (2017) (45)
Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center (2019) (45)
Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. (2006) (45)
Age-at-Onset in Late Onset Alzheimer Disease is Modified by Multiple Genetic Loci (2014) (44)
Interrater agreement for diagnosis of Alzheimer's disease (1994) (44)
Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease (2016) (43)
Duration and Pathologic Correlates of Lewy Body Disease (2017) (43)
Medical complications of ischemic stroke and length of hospital stay: experience in Seattle, Washington. (1999) (43)
Thinking Outside the Box: Alzheimer-Type Neuropathology That Does Not Map Directly Onto Current Consensus Recommendations (2010) (42)
A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. (2015) (41)
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium (2019) (41)
The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. (1999) (41)
Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. (2016) (41)
Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition (2016) (41)
Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease. (2008) (41)
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases (2020) (40)
Sex-specific genetic predictors of Alzheimer’s disease biomarkers (2018) (40)
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
Cognitive decline in Alzheimer's disease (1995) (40)
Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer's disease and in older persons with down's syndrome (1993) (40)
Calcium channel blockers and β-blockers in relation to Parkinson's disease (2007) (40)
Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer’s disease and cerebrovascular disease pathologies (2018) (39)
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy (2017) (38)
Challenges and Considerations Related to Studying Dementia in Blacks/African Americans. (2017) (37)
Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
Differences in rate of functional decline across three dementia types (2013) (36)
Relationship between serum α1-antichymotrypsin and Alzheimer's disease (1994) (36)
Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. (2014) (35)
Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. (2015) (34)
Older Adults and Functional Decline: A Cross-Cultural Comparison (2002) (33)
Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk (2016) (33)
Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples. (1996) (32)
Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging (2016) (32)
Developing a global strategy to prevent Alzheimer’s disease: Leon Thal Symposium 2010 (2011) (32)
Neighborhood built environment and cognition in non-demented older adults: The Multi-Ethnic Study of Atherosclerosis. (2018) (31)
Rapid Estimation of Hospitalization Charges From a Brief Medical Record Review: Evaluation of a Multivariate Prediction Model (1986) (31)
Association of TREM2 variants with Alzheimer's disease in African-Americans: For the Alzheimer's Disease Genetics Consortium (ADGC) (2013) (31)
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration (2019) (31)
Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework (2018) (30)
The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology (2019) (30)
Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course (2020) (29)
Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. (2020) (29)
Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia (2019) (28)
Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. (2018) (28)
Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease (1992) (28)
Theoretical Impact of Florbetapir (18F) Amyloid Imaging on Diagnosis of Alzheimer Dementia and Detection of Preclinical Cortical Amyloid (2014) (28)
Visual hallucinations in dementia: a prospective community-based study with autopsy. (2009) (27)
Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology (2015) (27)
Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E (2018) (27)
Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 (2021) (26)
Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. (2020) (26)
Progression of Alzheimer's disease in black and white patients (1998) (26)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition (2016) (25)
Lost in translation: epidemiology, risk, and Alzheimer disease. (2010) (25)
Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration (2019) (25)
Risk of dementia and mild cognitive impairment among older adults in same‐sex relationships (2019) (25)
Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease (2019) (24)
Milder Alzheimer's disease pathology in heart failure and atrial fibrillation (2017) (24)
Mitochondrial Genetic Variants and Alzheimer Disease: A Case-Control Study of the T4336C and G5460A Variants (2002) (24)
Sudden infant death and infanticide. (1977) (24)
Active and Passive Cigarette Smoking and Risk of Intracranial Meningioma (2005) (23)
Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease. (2016) (22)
Relationship between Cigarette Smoking and Alzheimer's Disease in a Population‐Based Case‐Control Study (1992) (22)
Are There Clinical and Epidemiological Differences between Familial and Non‐familial Alzheimer's Disease? (1991) (22)
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort (2020) (22)
Calcium channel blockers and beta-blockers in relation to Parkinson's disease. (2007) (21)
Social Relationships and Risk of Incident Mild Cognitive Impairment in US Alzheimer’s Disease Centers (2014) (21)
Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (2012) (20)
Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART) (2019) (20)
Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia (2020) (19)
Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer’s neuropathology (2018) (19)
Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer’s Disease (2006) (19)
Enhancing the Power of Genetic Association Studies through the Use of Silver Standard Cases Derived from Electronic Medical Records (2013) (19)
APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort (2019) (19)
Stroke risk factor knowledge in Hispanic and non-Hispanic white women in New Mexico: implications for targeted prevention strategies. (1998) (18)
Do cultural differences affect Alzheimer disease? (1996) (18)
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint (2019) (18)
Rates of lobar atrophy in asymptomatic MAPT mutation carriers (2019) (18)
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint (2019) (18)
Factors Influencing Successful Lumbar Puncture in Alzheimer Research (2017) (17)
Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults (2018) (17)
Big data, aging, and dementia: Pathways for international harmonization on data sharing (2013) (17)
Conjugal Alzheimer's disease: Is there an increased risk in offspring? (1993) (16)
Alzheimer's disease and history of blood transfusion by apolipoprotein-E genotype. (1997) (16)
The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology (2021) (16)
Anxiety in alzheimer's disease (1999) (15)
Associations between neighborhood built environment and cognition vary by apolipoprotein E genotype: Multi-Ethnic Study of Atherosclerosis. (2019) (15)
Mixed neuropathologies and associations with domain-specific cognitive decline (2017) (15)
Nonlinear Z-score modeling for improved detection of cognitive abnormality (2019) (14)
Limbic-Predominant Age-Related TDP-43 Encephalopathy (2022) (14)
Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores (2020) (14)
Alcohol, Gender, and Cognitive Performance (2004) (14)
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe (2021) (14)
Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers (2019) (13)
Distinguishing Alzheimer's Disease from Other Dementias (1989) (13)
Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly (2018) (13)
A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases (2016) (13)
Sleep in Alzheimer’s Dementia (1987) (12)
Clinician-judged hearing impairment and associations with neuropathologic burden (2020) (12)
Brain volumetric deficits in MAPT mutation carriers: a multisite study (2020) (12)
Relationship of age to incidence of breast cancer in young women. (1976) (12)
Risk of Decline in Functional Activities in Dementia With Lewy Bodies and Alzheimer Disease (2011) (12)
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring (2021) (11)
Role of brain infarcts in behavioral variant frontotemporal dementia Clinicopathological characterization in the National Alzheimer's Coordinating Center database (2015) (11)
On the uses of registries for Alzheimer disease. (1989) (11)
Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology (2017) (11)
Problems in Measuring and Interpreting Cognitive Decline (1998) (11)
Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy. (2020) (10)
The Utility of the National Alzheimer’s Coordinating Center’s Database for the Rapid Assessment of Evolving Neuropathologic Conditions (2020) (9)
The effect of diagnosing Alzheimer’s disease on frequency of physician visits (1995) (9)
FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease (2022) (9)
Personalized genetic assessment of age associated Alzheimer’s disease risk (2016) (9)
The growing global burden of dementia (2006) (9)
An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease (2007) (9)
Clinical and Surgical Factors Associated With Increased Epilepsy Risk in Children With Hydrocephalus. (2016) (9)
The Nevada Vital Aging Initiative: A private-public partnership to study early predictors of dementia (2007) (8)
Reply: LATE to the PART-y. (2019) (8)
Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease. (1994) (8)
Comparison of Alzheimer’s disease in American Indians, whites, and African Americans (2007) (8)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort (2020) (7)
Cognitive Impairment in Older Adults Without Dementia: Clinical and Pathologic Outcomes in a Community-Based Sample (2009) (7)
Differential Effect of Statins on Risk of AD by Age, Sex, and APOE Genotype: Findings From a Community-based Prospective Cohort Study (2006) (7)
APOE polymorphisms and late-onset Alzheimer disease: the importance of ethnicity. (1998) (6)
Divergent magnetic resonance imaging atrophy patterns in Alzheimer's disease and primary age-related tauopathy (2022) (6)
A Novel Study Paradigm for Long-term Prevention Trials in Alzheimer Disease: The Placebo Group Simulation Approach (PGSA): Application to MCI data from the NACC database. (2014) (6)
An apple a day to prevent Parkinson disease (2012) (6)
Anatomical configurations associated with posthemorrhagic hydrocephalus among premature infants with intraventricular hemorrhage. (2016) (6)
Risk of mild cognitive impairment among older adults in the United States by ethnoracial group (2020) (6)
Prevention of Alzheimer Disease: A Perspective Based on Successes in the Prevention of Other Chronic Diseases (1996) (6)
Primary neuropathologic diagnosis and co-occurrence of other neuropathologic features: Results from the National Alzheimer's Coordinating Center (NACC) (2009) (6)
Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease (2022) (5)
New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia (2018) (5)
Cross‐sectional differences in symptomatic presentation and cognitive performance among participants with LATE‐NC compared to FTLD‐TDP (2020) (5)
Interrater Reliability and Accuracy in Identifying Ischemic Strokes Using Computed Tomography Scans in People with Dementia (2005) (5)
Antithrombotic medication use and dementia incidence among people with mild cognitive impairment and atrial fibrillation (2013) (5)
Clinically Unsuspected Prion Disease Among Patients With Dementia Diagnoses in an Alzheimer’s Disease Database (2015) (4)
Factors influencing lumbar puncture participation in Alzheimer’s research (2015) (4)
Abstracts from Hydrocephalus 2016 (2017) (4)
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
Risk of alzheimer disease is associated with parental age among apolipoprotein E ε4 heterozygotes (1997) (4)
CHOLINESTERASE INHIBITOR USE AND COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER DISEASE (2017) (3)
Sex-dependent polygenic effects on the clinical progressions of Alzheimer’s disease (2019) (3)
Cognitive domain harmonization and cocalibration in studies of older adults. (2022) (3)
Effects of Age and Ethnicity on the Link Between APOE ∊4 and Alzheimer Disease—Reply (1998) (3)
Genetic differences between symptomatic and asymptomatic persons with Alzheimer's disease neuropathologic change (2015) (2)
COGNITIVE IMPAIRMENT IN PRIMARY AGE-RELATED TAUOPATHY VERSUS ALZHEIMER’S DISEASE (2018) (2)
THE NATIONAL ALZHEIMER'S COORDINATING CENTER: DEVELOPMENT OF THE MRI, PET AND CSF BIOMARKER DATABASES (2017) (2)
Factor Consistency of Neuropsychological Test Battery Versions in the NACC Uniform Data Set (2020) (2)
Neurologic diseases, epidemiology, and public health. (2009) (2)
THE NATIONAL ALZHEIMER'S COORDINATING CENTER MRI DATABASE (2014) (2)
Progranulin mutations in clinical and neuropathological Alzheimer's disease (2022) (2)
NONLINEAR N-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER (NACC) DATASET (2018) (2)
Multiple gene variants linked to Alzheimer’s-type clinical dementia via GWAS are also associated with non-Alzheimer’s neuropathologic entities (2022) (2)
No protective effect of education in Alzheimer's disease: Findings from the CERAD database (1998) (2)
Importance of coincident neurodegenerative diseases (2013) (1)
Association, cause, and causal association, revised: reasoning and methods (2020) (1)
Consensus diagnosis and predictors of diagnostic accuracy in the national Alzheimer's Disease Centers (2013) (1)
Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) (2019) (1)
EXPLORING THE LINK BETWEEN HEARING LOSS AND DEMENTIA: IS IMPAIRED HEARING ASSOCIATED WITH COMMON NEUROPATHOLOGIES? (2019) (1)
The validity of 3 clinical diagnostic criteria for Alzheimer??s disease (1991) (1)
Multidimensional Complexity in the Dementias: Diagnosis, Stage, Comorbidity, and Neuropsychiatric Symptoms (P07.160) (2012) (1)
MILD COGNITIVE IMPAIRMENT AMONG PARKINSON'S DISEASE SUBJECTS IN THE UNIFORM DATA SET (2014) (1)
Are some individuals immune to dementia? (2013) (1)
Age-dependent effects of APOE e 4 in preclinical Alzheimer’s disease (2016) (1)
THE NATIONAL ALZHEIMER'S COORDINATING CENTER: DEVELOPMENT OF THE MRI, PET AND CSF BIOMARKER DATABASES (2017) (1)
Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator (2023) (1)
Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease. (2022) (1)
The Asian Cohort for Alzheimer’s Disease (ACAD) study (2021) (1)
Cognitive aging with dementia, mild cognitive impairment (MCI), or no impairment: A comparison of same‐ and other‐sex couples (2021) (1)
Characteristics and Progress on 312 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol (P3.036) (2018) (1)
Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population (2022) (1)
The Alzheimer's Disease Centers' Neuropsychological Database Initiative: A Resource for Alzheimer's Disease Prevention Trials (2002) (1)
TRAUMATIC BRAIN INJURY (TBI) AND DEMENTIA PROGRESSION (2016) (1)
Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease (1998) (1)
AMultiancestral Genome-Wide Exome Array Study of Alzheimer Disease , Frontotemporal Dementia , and Progressive Supranuclear Palsy (2015) (1)
Validation of the Alzheimer's Prevention Initiative Composite Cognitive Test Score (2013) (1)
brain human functionally distinct regions of the normal aged Gene expression profiles in anatomically and (2015) (1)
CHARACTERISTICS AND PROGRESS ON THE INITIAL 209 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL (2017) (1)
Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide (2022) (1)
Classification of Stroke Cases in Administrative Data using ICD-9 Codes (2001) (1)
Is there selection bias in autopsy completion? Results from a community-based study (2000) (1)
Racial‐ethnic differences in baseline and longitudinal change in neuropsychological test scores in the NACC Uniform Data Set 3.0 (2021) (1)
Perspectives on shared genetic contributions for Parkinson disease and Alzheimer disease. (2004) (1)
Symptomatic presentation and cognitive performance in autopsy‐confirmed, limbic‐predominant, age‐related TDP‐43 encephalopathy with comorbid Alzheimer’s disease (2021) (1)
Risk factors for post-hemorrhagic hydrocephalus among infants with intraventricular hemorrhage (2015) (1)
P1-256 Age-dependent associations between blood pressure and risk of dementia: A community-based prospective cohort study (2006) (1)
P2–230: Withdrawn (2013) (0)
Neuropsychological markers of cognitive decline in persons with Alzheimer’s disease neuropathology (2015) (0)
APOE4 IS NOT A RISK FACTOR FOR ALZHEIMER’S DISEASE PATHOLOGY IN PPA, IRRESPECTIVE OF CLINICAL SUBTYPE (2018) (0)
Sex‐specific genetic predictors of memory performance (2021) (0)
VALIDATING THE PLACEBO GROUP SIMULATION APPROACH (PGSA): AN ALTERNATIVE STUDY DESIGN FOR PREVENTIVE TRIALS IN PRODROMAL AD PATIENTS (2014) (0)
Predicting Conversions from Normal to MCI and from MCI to AD with Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Big Data Analytics and Transition Probability Calculators (2022) (0)
Portuguese version of the CDR plus NACC FTLD: Validation studies (2022) (0)
List of contributors. (2019) (0)
Platelet membrane fluidity (1993) (0)
Memory clinics as vehicles of research into dementia: The NACC example (2020) (0)
Population-based analysis of medical complications and length of stay in patients hospitalized for ischemic stroke (1997) (0)
TRACKING WHITE MATTER DEGENERATION IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS WITH DTI (2019) (0)
PREVALENCE OF MILD COGNITIVE IMPAIRMENT IN APOE ε3/ε3 INDIVIDUALS WITH A FAMILY HISTORY OF ALZHEIMER’S DISEASE (2019) (0)
RHEUMATOID ARTHRITIS, INFLAMMATION TREATMENT, AND ALZHEIMER’S DISEASE: A CROSS-SECTIONAL DESCRIPTIVE STUDY USING THE NACC DATABASE (2018) (0)
Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol (2020) (0)
Neuropathological diagnoses in a community-based incident dementia case series (2000) (0)
P4-083 RACIAL DIFFERENCES OF INCIDENT ALZHEIMER’S DISEASE AS A FUNCTION OFAPOE4 (2018) (0)
Alzheimer Disease candidate variants are associated with cerebral amyloid angiopathy (2022) (0)
Clinical features that differentiate young‐onset AD from young‐onset FTLD: An examination of the NACC UDS 3.0 and FTLD Module (2021) (0)
THE NATIONAL ALZHEIMER'S COORDINATING CENTER: QUERYING THE DATABASE AND REQUESTING DATA (2017) (0)
Genetic Data Identify Dual‐enrolled Participants in Alzheimer's Disease and Related Dementia (ADRD) Studies (2022) (0)
P3-117 Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study (2004) (0)
Epidemiology, Risk, and Alzheimer Disease (2016) (0)
MULTIPLE FACTOR ANALYSIS OF NEUROPSYCHOLOGICAL TEST BATTERY CHANGE IN THE NATIONAL ALZHEIMER’S COORDINATING CENTER UNIFORM DATA SET (2019) (0)
Neuropsychiatric abnormalities in familial frontotemporal dementia: Findings from the LEFFTDS Cohort (2020) (0)
CLINICAL PROGRESSION IN MIXED NEUROPATHOLOGIES: TESTING INTERACTIONS OF LEWY BODIES AND VASCULAR BRAIN INJURY WITH ALZHEIMER'S DISEASE NEUROPATHOLOGIC CHANGE (2016) (0)
Family history and apoE genotype interaction in Alzheimer`s disease (AD) (1994) (0)
Longitudinal changes in FAQ scores by informant relationship (2020) (0)
Pulse pressure and atherosclerosis, arteriolosclerosis and cortical microinfarcts in individuals with clinical Alzheimer's disease (2013) (0)
Cluster analysis of neuropathologic features in the National Alzheimer’s Coordinating Center data set (2021) (0)
On the Uses of Regisries for Alzheimer Disease (1989) (0)
FMNL2 interacts with cerebrovascular risk factors to alter Alzheimer's disease risk (2020) (0)
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
Erratum (1979) (0)
The trajectory of cognitive decline and neuropathological features among APOEɛ2 carriers (2020) (0)
ASSOCIATIONS OF NEUROPATHOLOGY AND APOLIPOPROTEIN E GENOTYPE WITH DEMENTIA IN THE OLDEST-OLD COMPARED TO YOUNGER-OLD AGE GROUPS (2017) (0)
Educational Attainment in Patients with Frontotemporal Dementia and Primary Progressive Aphasia Compared to Other Dementia Syndromes (P03.089) (2013) (0)
CARDIOVASCULAR RISK FACTORS AND THEIR INTERACTIONS AMONG CLINICALLY DEFINED NEURODEGENERATIVE DISEASES (2014) (0)
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
Elucidating Subtypes and Risk Factors of Brain Arteriolosclerosis (P1.195) (2018) (0)
ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS (2017) (0)
CHARACTERISTICS AND PROGRESS OF 320 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL (2018) (0)
The NACC uniform data set (2010) (0)
EPILEPSY IN ALZHEIMER DISEASE IS FREQUENT AND CHARACTERIZED BY HIGH RECURRENCE (2019) (0)
Risk factors for post-hemorrhagic hydrocephalus among infants with intraventricular hemorrhage (2015) (0)
P3-166 Lewy body pathology in a large, autopsy confirmed, community-based dementia sample (2004) (0)
Family history, demographics, and genetic characteristics of symptomatic and non-symptomatic subjects with neuropathological Alzheimer's disease in the National Alzheimer's Coordinating Center (NACC) datasets (2010) (0)
P4-023 Depression within dementia subtypes: data from the national Alzheimer's coordinating center (2004) (0)
Cholinesterase inhibitors and memantine use in the National Alzheimer's Coordinating Center's Uniform Data Set: A longitudinal assessment of real-world medication use in dementia (2012) (0)
Title Age-dependent effects of APOE epsilon 4 in preclinical Alzheimer ' s disease (2016) (0)
Comparing Global measures of cognitive decline in amnestic mci subjects in the National Alzheimer's Coordinating Center (NACC) uniform data set (2011) (0)
Physician visit frequency in Alzheimer’s disease (1995) (0)
THE NATIONAL ALZHEIMER'S COORDINATING CENTER MRI DATABASE (2014) (0)
PHENOCONVERSION FROM ASYMPTOMATIC TO MINIMALLY SYMPTOMATIC FTLD: PRELIMINARY DATA IN THE LEFFTDS COHORT (2017) (0)
RACIAL DIFFERENCES OF INCIDENT ALZHEIMER’S DISEASE AS A FUNCTION OF APOE4 (2018) (0)
Comparison of neuropsychological test scores among English and Spanish speakers in a multi-regional sample of cognitively normal subjects (2012) (0)
EFFECTS OF AGE AND ETHNICITY ON THE LINK BETWEEN APOE EPSILON 4 AND ALZHEIMER DISEASE. AUTHORS' REPLY (1998) (0)
Contents (2009) (0)
New data gathering, instrument selection, and evaluation of existing information for determining entry (1990) (0)
Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration (2021) (0)
TRAJECTORY OF NEUROPSYCHOLOGICAL TEST SCORES IN MILD COGNITIVE IMPAIRMENT COMPARING PRIMARY AGE-RELATED TAUOPATHY VERSUS ALZHEIMER DISEASE (2019) (0)
DIFFERENCES BETWEEN SPORADIC AND FAMILIAL BEHAVIORAL VARIANT FTD IN ADVANCING RESEARCH AND TREATMENT FOR FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM (2018) (0)
Neuropathological Influences on the Clinical Phenotype of Synucleinopathies (P6.225) (2016) (0)
Alzheimer’s Disease and the Search for Environmental Risk Factors (2015) (0)
P3-190 Lewy Body (LB) pathology and clinical diagnoses in the National Alzheimer’s Coordinating Center (NACC) database (2006) (0)
FRONTOTEMPORAL LOBAR DEGENERATION RESEARCH IN NORTH AMERICA: PROGRESS IN THE ARTFL/LEFFTDS CONSORTIA (2019) (0)
Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART) (2019) (0)
NEUROPATHOLOGICAL FEATURES IN PARTICIPANTS WITH SLEEP DISORDERS: A CROSS-SECTIONAL DESCRIPTIVE STUDY USING THE NACC DATABASE (2019) (0)
DISPARITIES IN THE COGNITIVE TRAJECTORY OF LATINO MCI PARTICIPANTS: AN ANALYSIS OF THE NACC DATABASE (2019) (0)
LATENT ANALYSIS OF EXTRAPYRAMIDAL SIGNS IN ALZHEIMER'S DISEASE IDENTIFIES DISTINCT DISEASE EXPRESSIONS (2014) (0)
Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease in the National Alzheimer's Coordinating Center Neuropathology data set (2013) (0)
Human Responses to Cancer (1984) (0)
Featured Article Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (0)
Longitudinal GWAS Identifies Novel Genetic Variants and Complex Traits Associated with Resilience to Alzheimer’s Disease (2022) (0)
P2-117 The national Alzheimer’s coordinating center’s data submission system and database (2006) (0)
Acta Neuropathologica ABCC 9 gene polymorphism is associated with hippocampal sclerosis of aging pathology (2017) (0)
Cognitive performance among participants with Alzheimer’s disease and cerebral amyloid angiopathy (2020) (0)
Sex‐specific genetic predictors of memory, executive function, and language performance (2022) (0)
Multimodal genome‐wide meta‐analysis of brain amyloidosis reveals heterogeneity across CSF, PET, and pathological amyloid measures (2020) (0)
Aging 6-2019 Limbic-Predominant Age-Related TDP-43 Encephalopathy ( LATE ) : Consensus Working Group Report (2019) (0)
LONGITUDINAL COGNITIVE PERFORMANCE IN PARTICIPANTS WITH MILD COGNITIVE IMPAIRMENT AND IMPAIRED AWARENESS OF DECLINE (2019) (0)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005Y2010 (2012) (0)
INCIDENCE OF DEMENTIA SUBTYPES IN A COMMUNITY-BASED PROSPECTIVE COHORT STUDY: THE ADULT CHANGES IN THOUGHT (ACT) STUDY (2016) (0)
The status of digital pathology and machine learning within Alzheimer’s Disease Centers (2020) (0)
Abstracts from Hydrocephalus 2016 (2017) (0)
Neuropsychiatric symptoms in mild Alzheimer's disease: The influence of research study informants (2012) (0)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
THE CLINICAL SPECTRUM OF FRONTOTEMPORAL LOBAR DEGENERATION IN NORTH AMERICA: BASELINE CHARACTERISTICS OF THE FIRST 912 PARTICIPANTS FROM THE ADVANCING RESEARCH AND TREATMENT IN FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM (2018) (0)
AFRICAN AMERICAN BRAIN AUTOPSIES FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER (2016) (0)
P1-497 CLINICAL CORRELATES OF LEWY BODY PATHOLOGY IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE OPHTHALMOLOGY-BASED AD RISK FACTORS: DIABETIC RETINOPATHY IS ASSOCIATED WITH DEEP MICROINFARCTS IN A COMMUNITY-BASED AUTOPSY STUDY PRIMARYAGE-RELATED TAUOPATHY VERSUS ALZHEIMER’S NEUROPATHOLOGY (2018) (0)
APOE-ɛ4 and clinical progression in Parkinson's disease (2013) (0)
PLASMA AMYLOID, INFLAMMATORY MARKERS, AND TIME TO DEMENTIA IN THE GINKGO EVALUATION OF MEMORY STUDY (2019) (0)
enzyme-linked immunosorbent NONLINEAR N-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM (2018) (0)
Aluminum , Drinking Water , and Alzheimer ' s Disease [ Project (2010) (0)
Neurological diseases, epidemiology, and public health (2021) (0)
GRAY MATTER DEFICITS IN SYMPTOMATIC AND PRESYMPTOMATIC MAPT MUTATION CARRIERS (2018) (0)
Statin therapy and risk of dementia in the elderly [4] (multiple letters) (2005) (0)
The Asian Cohort for Alzheimer’s Disease (ACAD) Pilot Study (2022) (0)
Development of harmonized and co‐calibrated scores for memory, executive functioning, language, and visuospatial in the AIBL Study, ADNI, and NACC datasets (2022) (0)
THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS (2019) (0)
P3-110 Public-use data from NACC (2004) (0)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
ASSOCIATION BETWEEN ANTIDEPRESSANT USE AND INCIDENT MCI IN OLDER ADULTS WITH DEPRESSION (2017) (0)
Similar maximal educational attainment in people with dementia: Association with pathologically diagnosed frontotemporal lobar degeneration, Alzheimer's disease and Lewy body disease? (2013) (0)
Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples. (2023) (0)
P1-112 Neuropsychological characterization of dementia with Lewy bodies in a community-based, autopsy sample of dementia (2004) (0)
Sex differences in APOE effects on cognition are domain‐specific (2022) (0)
Differentiating among stages of cognitive impairment: Comparisons of versions two and three of the National Alzheimer’s Coordinating Center (NACC) Uniform Data Set (UDS) neuropsychological test battery (2020) (0)
Impact of time-scale choice on rate of cognitive decline: A case study from the national Alzheimer’s coordinating center minimum data set (2005) (0)
Sex differences in rate of progression of three dementia types (2012) (0)
O1-04-07 ″Amygdala predominant″ Lewy body disease: A subtype of Alzheimer’s disease with a more aggressive clinical course (2006) (0)
APOE4 NON-CARRIERS WITH THE CLINICAL DIAGNOSIS OF ALZHEIMER'S DEMENTIA AND MINIMAL AMYLOID HISTOPATHOLOGY (2014) (0)
by flavonoids An apple a day to prevent Parkinson disease : Reduction of risk (2012) (0)
P-169 Association between statins and risk of AD is age dependent (2007) (0)
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
THE NIH-EXAMINER IS SENSITIVE TO COGNITIVE CHANGES IN ASYMPTOMATIC AND MILDLY SYMPTOMATIC FAMILIAL FRONTOTEMPORAL DEMENTIA (2018) (0)
INCIDENT DEMENTIA IN NON-HISPANIC AFRICAN AMERICANS AND WHITES WITH MILD COGNITIVE IMPAIRMENT: CAN WE MAKE RACIAL COMPARISONS USING ALZHEIMER’S DISEASE CENTER DATA? (2018) (0)
Comparison of clinical and neuropathological definitions of alzheimer's disease at national institute on aging Alzheimer's disease centers, 2005-2010 (2011) (0)
P1-136 Examining the agreement between CERAD and NIA/Reagan Institute neuropathological criteria for the diagnosis of Alzheimer's disease (2004) (0)
Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer’s disease and cerebrovascular disease pathologies (2018) (0)
Association, Cause and Causal Association (2014) (0)
Web-based Data Quality Assurance Reports at the National Alzheimer's Coordinating Center (NACC) (2007) (0)
RISK FACTORS FOR CLINICAL AD IN U.S. LATINO POPULATIONS: AN ANALYSIS OF THE NACC DATABASE (2018) (0)
USING A BRAIN NETWORK APPROACH TO PREDICT GENETIC MUTATION IN INDIVIDUAL PATIENTS WITH FAMILIAL FRONTOTEMPORAL DEMENTIA (2018) (0)
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” “Big Asks”: What can be changed to increase and speed progress on Alzheimer's disease research and treatment? (2009) (0)
The status of digital pathology and associated infrastructure within Alzheimer’s Disease Centers (2023) (0)
Genome‐wide interaction study of smoking in Alzheimer’s disease (2020) (0)
Does hypertension affect the risk and age at onset of Alzheimer disease? (2000) (0)
Vascular neuropathology in dementia patients receiving antipsychotic therapy (2013) (0)
DEMENTIA DIAGNOSES, NEUROPSYCHIATRIC SYMPTOMS AND PHYSICAL COMORBIDITIES (2012) (0)
THE CONTRIBUTION OF SEX-SPECIFIC ASSOCIATIONS IN GENETIC STUDIES OF ALZHEIMER’S DISEASE PATHOLOGY (2018) (0)
associated Alzheimer disease risk : Development and validation of a polygenic hazard score Permalink (2017) (0)
THE NATIONAL ALZHEIMER'S COORDINATING CENTER: QUERYING THE DATABASE AND REQUESTING DATA (2017) (0)
Clinic‐based data serving Population Neuroscience: NACC example (2021) (0)
Hippocampal sclerosis of aging, a key potential Alzheimer’s disease confounder: The NACC experience (2013) (0)
Adverse drug reactions associated with global cognitive impairment in elderly persons (1988) (0)
PULSE PRESSURE IN LATE-LIFE AND ALZHEIMER’S AND CEREBROVASCULAR NEUROPATHOLOGY (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Walter A. Kukull?

Walter A. Kukull is affiliated with the following schools:

University of Washington

Walter A. Kukull's Academic­Influence.com Rankings